HMTM

Class [005]
Pharmaceutical preparations, medical preparations, chemical preparations for medical and pharmaceutical purposes and diagnostic preparations for humans and animals namely: antibiotics, antivirals and antiprotozoals; pharmaceutical preparations, medical preparations, chemical preparations for medical and pharmaceutical purposes and diagnostic preparations for humans and animals in relation to: neoplasms; neurodegenerative disorders namely Alzheimer's disease, Parkinson's disease, Huntington's disease, spinocerebellar ataxia, amyotrophic lateral sclerosis, dementia with Lewy bodies, Pick's disease, frontotemporal dementia, behavioural variant frontotemporal dementia, primary progressive aphasia, Down's syndrome, chronic traumatic encephalopathy, argyrophilic disease, progressive supranuclear palsy, frontotemporal dementia with parkinsonism linked to chromosome 17, disinhibition-dementia-parkinsonismamyotrophy complex, pallido-ponto-nigral degeneration, Guam-ALS syndrome; pallido-nigro-luysian degeneration, cortico-basal degeneration, mild cognitive impairment, multiple system atrophy, drug-induced parkinsonism, and pure autonomic failure and tauopathies, synucleinopathies and TDP-43 proteinopathies, prion diseases, Creutzfeldt-Jakob disease, Sanfilippo syndrome, Niemann-Pick type C disease and Lafora disease; psychiatric diseases, namely, schizophrenia, mood disorders, anxiety disorders, and cognitive disorders; cancer; methemoglobinemia; hypoxia; hypoxemia; anemia; chronic obstructive pulmonary disease; viral diseases, namely herpes, hepatitis, acquired immune deficiency syndrome, COVID-19 and West Nile virus infection; and protozoal diseases, namely malaria, visceral leishmaniasis; African sleeping sickness, toxoplasmosis, giardiasis, and Chagas' disease.